Inhibitor of the transcription factor NF-κB, DHMEQ, enhances the effect of paclitaxel on cells of anaplastic thyroid carcinoma in vitro and in vivo / Pushkarev, V. V., Starenki, D. V., Pushkarev, V. M., Kovzun, O. I., Tronko, M. D. (2015)
web address of the page http://jnas.nbuv.gov.ua/article/UJRN-0000423893
The Ukrainian Biochemical Journal   А - 2019 /  Issue (2015, Vol. 87, № 3)
Pushkarev V. V., Starenki D. V., Pushkarev V. M., Kovzun O. I., Tronko M. D.
Inhibitor of the transcription factor NF-κB, DHMEQ, enhances the effect of paclitaxel on cells of anaplastic thyroid carcinoma in vitro and in vivo
Cite:
Pushkarev, V. V., Starenki, D. V., Pushkarev, V. M., Kovzun, O. I., Tronko, M. D. (2015). Inhibitor of the transcription factor NF-κB, DHMEQ, enhances the effect of paclitaxel on cells of anaplastic thyroid carcinoma in vitro and in vivo. The Ukrainian Biochemical Journal , 87 (3), 63-74. http://jnas.nbuv.gov.ua/article/UJRN-0000423893 | |
|
|
PDF